(2005). AE: Repopulation of human pulmonary epithelium by bone marrow cells: a potential means to promote repair. Tissue Eng
(2009). AJ: Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax
(2002). Anversa P: Chimerism of the transplanted heart.
(2008). Bone marrow-derived cells and stem cells in lung repair. Proc Am Thoracic Soc
(2000). BP: Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg
(1992). Cell migration, chimerism, and graft acceptance. Lancet
(2009). Chambers DC: Cells of epithelial lineage are present in blood, engraft the bronchial epithelium, and are increased in human lung transplantation. J Heart Lung Transplant
(2003). Chimerism in organ transplantation: conflicting experiments and clinical observations. Transplantation
(2001). Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet
(2000). Epithelial regrowth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats. Transplantation
(2003). GS: Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med
(1999). Harjula AL: Alloimmune injury preceding airway obliteration in porcine heterotopic lung implants: a histologic and immunohistologic study. Transplantation
(2001). Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis. Transplantation
(2008). Immunosuppressive therapy and tolerance of organ allografts.
(2005). Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas. J Heart Lung Transplant
(2006). Kreipe H: Fibroblasts of recipient origin contribute to broncholitis obliterans in human lung transplants. Verh Dtsch Ges Pathol
(2002). Kreipe H: High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology
(2003). Kreipe H: Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury.
(1999). Kubickova S: Aneuploidy in pig sperm: multicolor fluorescence in situ hybridization using probes for chromosomes 1, 10, and Y. Cytogenet Cell Genet
(2004). MH: Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Transplant Proc
(2004). Mohanakumar T: Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease.
(2005). MR: Simultaneous LFA-1 and CD40 ligand antagonism prevents airway remodeling in orthotopic airway transplantation: implications for the role of respiratory epithelium as a modulator of fibrosis.
(2006). Pham SM: CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
(1993). Rudert WA: Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher’s disease.
(2005). Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model. Chest
(2008). SM: Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
(2007). T: Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft.
(2002). The use of laser microdissection for the preparation of chromosome-specific painting probes in farm animals. Chromosome Res
(2008). Tolerance and chimerism after renal and hematopoietic-cell transplantation.
(2003). Tolerance induction in clinical transplantation: the pending questions. Transplantation
(2004). US: Cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis.
(2007). Yousem SA: Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant
(2006). Zinkernagel RM: Microchimerism maintains deletion of the donor cellspecific CD8+ T cell repertoire.